Multi-center Study of Detection of Synchronous and Metachronous Contralateral Breast Cancer with Magnetic Resonance Imaging in Patients with Unilateral Breast Cancer

Multi-center Study of Detection of Synchronous and Metachronous Contralateral Breast Cancer with Magnetic Resonance Imaging in Patients with Unilateral Breast Cancer - Multi-center Study of Detection of Synchronous and Metachronous Contralateral Breast Cancer with Magnetic Resonance Imaging in Patients with Unilateral Breast Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003122

Enrollment

660

Registered

2010-02-03

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

MRI evaluation of bilateral breast

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: histologically proven invasive breast cancer ipsilateral breast cancer no evidence of metastasis

Exclusion criteria

Exclusion criteria: bilateral breast cancer Has a contraindication to undergoing breast MRI Patient is pregnant Has a psychiatric or addictive disorder that would preclude obtaining informed consent or adherence to the protocol

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity, positive and negative predictive value of breast MRI to detect the contralateral breast cancer	—

Secondary

Measure	Time frame
Safety of breast MRI, identification of lifestle risk factors about contralateral breast cancer	—

Countries

Japan

Contacts

Public ContactNaruto Taira

Okayama university hospital Breast and endocrine surgery

ntaira@md.okayama-u.ac.jp086-235-7265

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026